Genus plc Given “Buy” Rating at Liberum Capital (GNS)
Genus plc (LON:GNS)‘s stock had its “buy” rating reaffirmed by Liberum Capital in a research note issued on Monday. They currently have a GBX 1,400 ($23.54) target price on the stock. Liberum Capital’s target price indicates a potential upside of 33.97% from the company’s current price.
Shares of Genus plc (LON:GNS) traded down 0.19% on Monday, hitting GBX 1038.00. The stock had a trading volume of 5,638 shares. Genus plc has a one year low of GBX 924.50 and a one year high of GBX 1490.00. The stock’s 50-day moving average is GBX 1045. and its 200-day moving average is GBX 1163.. The company’s market cap is £628.0 million.
Several other analysts have also recently commented on the stock. Analysts at N+1 Singer reiterated a “hold” rating on shares of Genus plc in a research note on Friday. They now have a GBX 1,000 ($16.81) price target on the stock. Separately, analysts at Nplus1 Brewin reiterated a “hold” rating on shares of Genus plc in a research note on Tuesday, May 27th. They now have a GBX 1,000 ($16.81) price target on the stock. One analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company. Genus plc has an average rating of “Hold” and a consensus price target of GBX 1,264.14 ($21.25).
Genus plc is a United Kingdom-based company. The Company is engaged in applying quantitative genetics and biotechnology to animal breeding in the bovine and porcine sectors.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.